InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（12 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
12
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Bothwell Ian T, 首席财务官. Officer active across 2 companies, notably Organicell Regenerative Medicine, Inc.. Aggregated, 15 disclosures have been logged. Split: 0 buy · 12 sells. Total volume traded: €99k. History available since 3 May 2021. The latest transaction was disclosed on 14 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Bothwell Ian T
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
175,000 股0Common StockSEC:0001829126-26-000368:0
50 股0Series C PreferredSEC:0001829126-24-008636:0
15,000,000 股Common StockSEC:0001683168-21-005202:0
50,000 股@ US$0.1385.8% 占其流量Common StockSEC:0001683168-21-002663:0
50,000 股@ US$0.145.8% 占其流量Common StockSEC:0001683168-21-002587:0
50,000 股@ US$0.1476.1% 占其流量Common StockSEC:0001683168-21-002506:0
50,000 股@ US$0.145.8% 占其流量Common StockSEC:0001683168-21-002428:0
50,000 股@ US$0.1927.9% 占其流量Common StockSEC:0001683168-21-002362:0
40,000 股@ US$0.1936.4% 占其流量Common StockSEC:0001683168-21-002284:0
50,000 股@ US$0.187.4% 占其流量Common StockSEC:0001683168-21-002229:0
50,000 股@ US$0.229.1% 占其流量Common StockSEC:0001683168-21-002143:0
50,000 股@ US$0.2711.3% 占其流量Common StockSEC:0001683168-21-002078:0
50,000 股@ US$0.27411.4% 占其流量Common StockSEC:0001683168-21-001933:0
50,000 股@ US$0.30112.6% 占其流量Common StockSEC:0001683168-21-001828:0
50,000 股@ US$0.2510.4% 占其流量Common StockSEC:0001683168-21-001788:0
15 条申报中的 15 条
About Bothwell Ian T
Ian T. Bothwell is the Chief Financial Officer of Organicell Regenerative Medicine, Inc.
